New studies on krill oil, egg phospholipids, and phospholipid-based curcumin
NattoPharma’s Research Network Receives €4M EU Grant to Fund Research on Vitamin K2 and Vascular Health
NattoPharma announced that the company’s NattoPharma International Research Network has received a €4 million grant from the European Commission’s research program, Horizon 2020, to study vitamin K2’s role in vascular health.
Physicians’ Health Study II Finds No Clear Link between Multivitamin Use, Reduced CVD Risk, in Subjects with Less-Nutritious Diets
In a newly published, secondary analysis of the Physicians’ Health Study II, researchers posit that multivitamin supplementation did not help to prevent the risk of cardiovascular disease (CVD) events, even in subjects who were found to have less-nutritious diets.
The company says this product offers sustainability benefits by enabling the company to use the entire beet crop.
American Heart Association Recommends Omega-3 Supplements for Secondary Prevention of Coronary Heart Disease
This recommendation is a positive update to a previous AHA scientific recommendation the association published back in 2002.
FDA draft guidance has given the sodium-reduction movement new life, and ingredients old and new are rising to the challenge.
New study results suggest Oxyjun, an arjuna extract developed by Enovate Biolife, may increase cardiovascular efficiency and improve cardiac conditioning in young men.
The supplement is packaged with test strips that enable consumers to asses their own nitric oxide levels before and after using the supplement.
The brand has debuted an improved grade of its K-Real krill oil that it says is free of both trimethylamine (TMA) and trimethylamine-oxide (TMAO).
Two recent studies suggest that the inactive MGP, a vitamin K–dependent protein, is associated with cardiovascular stiffness in patients with diabetes or chronic kidney disease.